pembrolizumab,bevacizumab
merck,roche
['gyn', 'keynote-826', 'pembro']
#asco22 #gyn oral sessions: keynote-826 pembro + chemo +/- bev with persistant, recurrent or metastatic #cervical cancer improved pfs and os #gynsm 
CME experts Sara Fagerlie, PhD, CHCP and Mindy Tanzola, PhD founded Front Row CME to help clinicians and educators manage the oncology information deluge.